Epigral Limited has informed the Exchange regarding Board meeting held on January 30, 2026.

Epigral Limited has informed the stock exchanges that a meeting of its Board of Directors was held on January 30, 2026. This is a routine regulatory disclosure required under SEBI's Listing Obligations and Disclosure Requirements Regulations. The filing itself does not specify any decisions, approvals, or outcomes from the meeting. Investors will need to look at the company's subsequent filings (such as results, outcome of board meeting, or any other specific intimation) to understand what was discussed or approved. This type of filing generally precedes announcements on financial results, dividend declarations, fundraising, or other material corporate actions.